MaxCyte MXCT Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by MaxCyte in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about MaxCyte's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MaxCyte's accrued expenses?
- MaxCyte (MXCT) reported accrued expenses of $4.37M in Q1 2026.
- How has MaxCyte's accrued expenses changed year-over-year?
- MaxCyte's accrued expenses decreased by 13.2% year-over-year, from $5.03M to $4.37M.
- What is the long-term trend for MaxCyte's accrued expenses?
- Over 5 years (2020 to 2025), MaxCyte's accrued expenses has grown at a 8.0% compound annual growth rate (CAGR), from $5.31M to $7.81M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.